Abstract
The association between C-reactive protein (CRP) and future cardiovascular risk has been of particular interest during recent years. Oxidized low-density lipoprotein (ox-LDL) is another marker linking the immune system with the atherogenic process. The aim of this study was to examine whether ox-LDL and CRP were associated with endothelial function in peripheral resistance arteries. Twenty-five men with a previous hospital-diagnosed myocardial infarction were enrolled in the study. The exclusion criterion was a history of diabetes mellitus. IgG and IgM autoantibodies to malonyldialdehyde low-density lipoprotein (MDA-LDL) and high-sensitivity CRP (hs-CRP) were measured. Flow-mediated dilatation was measured in isolated resistance arteries from subcutaneous fat biopsies. Endothelial function test reflecting the maximum vessel dilatation in male subjects was inversely related to MDALDL IgG autoantibody levels (r = −0.6 and P = 0.003). Comparison of hs-CRP levels and of maximum vessel dilatation in males revealed also an inverse relation (r= −0.4 and P = 0.04). In conclusion, a clear correlation exists between flow-mediated dilatation in subcutaneous resistance arteries and plasma levels of MDA-LDL IgG autoantibody and CRP in male patients with coronary heart disease.
Similar content being viewed by others
References
Steinberg D (1997) Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272:20963–20966
Volanakis JE (2001) Human C-reactive protein: expression, structure, and function. Mol Immunol 38:189–197
Gershov D, Kim S, Brot N, Elkon KB (2000) C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components and sustains an inflammatory innate response: implications for systemic autoimmunity. J Exp Med 192:1353–1364
Chang MI-K, Binder CJ, Torzewski M, Witztum J (2002) Creactive protein bind to both LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phosphoplipids. Proc Natl Acad Sci USA 99:13043–13048
Witztum JL, Berliner JA (1998) Oxidized phospholipids and isoprostanes in atherosclerosis. Curr Opin Lipidol 9:441–448
Holovet P, Collen D, Van de Werf F (1999) Malondialdehydemodified LDL as a marker of acute coronary syndromes. JAMA 281:1718–1721
Tsimikas S, Palisnski W, Witztum J (2001) Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor deficient mice. Arterioscler Thromb Vasc Biol 21:95–100
Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen, Palinski W, Witztum JL.(1992) Autoantibody against oxidized LDL and progession of carotid atherosclerosis. Lancet 339:8883–8887
Meraviglia MV, Maggi E, Bellomo G, Cursi M, Fanelli G, Minicucci F (2002) Autoantibodies against oxidatively modified lipoproteins and progression of carotid restenosis after endarterectomy. Stroke 33:1139–1141
Dotevall A, Hulte J, Rosengren A, Wiklund O, Wilhemsen L (2001) Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women. Clin Sci 101:523–531
Chowiwnczyk PJ, Cockcroft JR, Ritter JM (1994) Blood flow responses to intra-arterial acetycholine in man: effects of basal flow and conduit vessel length. Clin Sci 87:45–51
Palinski W, Horkko S, Miller E, Steinbrecher UP, Powell HC, Curtiss LK, Witztum JL (1996) Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice: demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 98:800–814
Tsimikas S, Bergmark C, Beyer RW, Patel R, Pattison J, Miller E, Juliano J, Witzum JL (2003) Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 41:360–370
Chenillot O, Henny J, Steinmetz J, Herbeth B, Wagner C, Siest G (2000) High sensitivity C-reactive protein: biological variations and reference limits. Clin Chem Lab Med 38:1003–1011
Kublickiene KR, Cockell AP, Nisell H, Poston L (1997) Role of nitric oxide in the regulation of vascular tone in pressurized and perfused resistance myometrial arteries from term pregnant women. Am J Obstet Gynecol 177:1263–1269
Svedas E, Islam KB, Nisell H, Kublickiene KR (2003) Vascular endothelial growth factor induced functional and morphologic signs of endothelial dysfunction in isolated arteries from normal pregnant women. Am J Obstet Gynecol 188:168–176
Vergnani L, Hatrik S, Ricci F, Passaro A, Manzoli N, Zuliani G, Brovkovych V, Fellin R, Malinski T (2000) Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production: key role of L-arginine availability. Circulation 101:1261–1266
Gokce N, Keaney JF Jr, Hunter LM (2002) Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 105:1567–1572
Neunteufl T, Heher S, Katzenschlager R (2000) Late prognostic value of flow-mediated dilatation in the brachial artery of patients with chest pain. Am J Cardiol 86:207–210
Heitzer T, Luoma J, Kurz S, Munzel T, Just H, Olschewski M, Drexler H (1996) Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL. Circulation 93:1346–1353
Agewall S, Henareh L, Kublickiene K (2006) Endothelial function in conduit and resistance arteries in men with coronary disease. Atherosclerosis 184:130–136
Fang C J, Kinlay S, Behrendt D, Hikita H, Witztum JL, Selwyn AP, Ganz P (2003) Circulating autoantibodies to oxidized LDL correlate with impaired coronary endothelial function after cardiac transplantation. Arterioscl Thromb Vascul Biol 22:2044–2048
Crisby M, Fredriksson-Norden G, Shah PK, Yano J, Zhu J, Nilsson J (2001) Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases and cell death in human carotid plaques. Implications for plaque stabilisation. Circulation 103:926–933
Kanadasi M, Cayli M, Demirtas M, Inal T, Demir M, Koç M, Avkaroğullari M, Dönmez Y, Usal A, Alhan CC, San M (2006) The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol. Heart Vessels 21:291–297
Binder CJ, Horkko S, Dewan A, Chang MK, Kieu EP, Goodyear CS, Shaw PX, Palinski W, Witztum JL, Silverman GJ (2003) Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 6:736–743
Karvonen J, Paivansalo M, Kesaniemi YA, Horkko S (2003) Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 108:2107–2112
Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397
Chen MC, Chen CJ, Yang CH, Wu CJ, Fang CY, Hsieh YK, Chang HW (2007) Interleukin-18: a strong predictor of the extent of coronary artery disease in patients with unstable angina. Heart Vessels 22:371–375
Murasaki S, Murasaki K, Tanoue K, Kawana M, Hagiwara N, Kasanuki H (2007) Circulating platelet and neutrophil activation correlates with the clinical course of unstable angina. Heart Vessels 22:376–382
Pasceri V, Cheng JS, Willerson JT, Yeh ET, Chang J (2001) Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103:2531–2534
Crisby M, Kallin B, Thyberg J, Zhivotovsky B, Orrenius S, Kostulas V, Nilsson J (1997) Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. Atherosclerosis 130: 17–27
Tomai F, Crea F, Gaspardone A, Versaci F, Ghini AS, Chiariello L, Gioffre PA (2001) Unstable angina and elevated C-reactive protein levels predict enhanced vasoreactivity of the culprit lesion. Circulation 104:1471–1476
Teragawa H, Fukuda Y, Matsuda K, Ueda K, Higashi Y, Oshima T, Yoshizumi M, Chayama K.(2004) Relation between C reactive protein concentrations and coronary microvascular endothelial function. Heart 90:750–754
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Crisby, M., Kublickiene, K., Henareh, L. et al. Circulating levels of autoantibodies to oxidized low-density lipoprotein and C-reactive protein levels correlate with endothelial function in resistance arteries in men with coronary heart disease. Heart Vessels 24, 90–95 (2009). https://doi.org/10.1007/s00380-008-1089-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-008-1089-y